A series of aryl piperazine compounds are effective pharmaceuticals for the treatment
of conditions related to or affected by the serotonin 1A receptor; the
compounds are particularly effective antagonists at that receptor, and are particularly
useful for alleviating the symptoms of nicotine and tobacco withdrawal.
